Keywords: novartis/intercell, ixiaro, cleared, europe, swiss, drug, major

Novartis/Intercell's Ixiaro cleared in Europe

Article | 28 April 2009

Print This

Swiss drug major Novartis' Japanese encephalitis vaccine Ixiaro has been approved in Europe. The product is the first of its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in